Loading...
India's olaparib imports from CHINA total $14.8K across 7 shipments from 2 foreign suppliers. DR.REDDYS LABORATORIES LIMITED leads with $12.3K in import value; the top 5 suppliers together control 100.0% of this origin. Leading Indian buyers include DR.REDDY'S LABORATORIES LTD. This corridor reflects India's pharmaceutical import demand for olaparib — a concentrated sourcing relationship with select suppliers from CHINA.
DR.REDDYS LABORATORIES LIMITED is the leading Olaparib supplier from CHINA to India, with import value of $12.3K across 4 shipments. The top 5 suppliers — DR.REDDYS LABORATORIES LIMITED, QILU PHARMACEUTICAL (HAINAN) CO. LTD. — collectively account for 100.0% of total import value from this origin.
Ranked by import value (USD) · Indian Customs (DGFT) data
| # | Supplier | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | DR.REDDYS LABORATORIES LIMITED | $12.3K | 4 | 82.9% |
| 2 | QILU PHARMACEUTICAL (HAINAN) CO. LTD. | $2.5K | 3 | 17.1% |
Ranked by import value (USD)
| # | Buyer | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | DR.REDDY'S LABORATORIES LTD | $12.3K | 4 | 82.9% |
| 2 | CBCC GLOBAL RESEARCH LLP | $2.5K | 3 | 17.1% |
Answers based on Indian Customs (DGFT) import records compiled by TransData Nexus
The top Olaparib suppliers from CHINA to India include DR.REDDYS LABORATORIES LIMITED, QILU PHARMACEUTICAL (HAINAN) CO. LTD.. The leading supplier is DR.REDDYS LABORATORIES LIMITED with import value of $12.3K USD across 4 shipments. India imported Olaparib worth $14.8K USD from CHINA in total across 7 shipments.
India imported Olaparib worth $14.8K USD from CHINA across 7 shipments. Data is from Indian Customs (DGFT) records. Values are in USD.
The main Indian buyers of Olaparib sourced from CHINA include DR.REDDY'S LABORATORIES LTD, CBCC GLOBAL RESEARCH LLP. The largest buyer is DR.REDDY'S LABORATORIES LTD with $12.3K in imports across 4 shipments.
The total value of Olaparib imports from CHINA to India is $14.8K USD, across 7 shipments and 2 foreign suppliers. Data source: Indian Customs (DGFT).
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
7 Verified Shipments
2 suppliers, 2 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists